CLNN - Clene Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.58 0.3 (3.5%) --- --- --- --- 0.3 (3.5%) --- ---

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.78
Diluted EPS:
Basic P/E:
-11.3846
Diluted P/E:
RSI(14) 1m:
72.41
VWAP:
8.85
RVol:
0.2404

Events

Period Kind Movement Occurred At
1m Price decrease 1m 8.56 -0.09 (-1.01%) Oct 15 13:34
1m Price decrease 1m 8.64 -0.1 (-1.14%) Oct 15 13:17
1m Price increase 1m 8.86 +0.1 (+1.14%) Oct 15 11:58
1m Price increase 1m 8.79 +0.17 (+2.0%) Oct 15 11:56
1m Price increase 1m 8.66 +0.1 (+1.19%) Oct 15 10:22

Related News